Randomized Trial of Hydroxychloroquine for Newly Diagnosed Chronic Graft-versus-Host Disease in Children: A Children’s Oncology Group Study

MLA

Indira Sahdev, et al. “Randomized Trial of Hydroxychloroquine for Newly Diagnosed Chronic Graft-versus-Host Disease in Children: A Children’s Oncology Group Study.” Biology of Blood and Marrow Transplantation, vol. 18, Jan. 2012, pp. 84–91. EBSCOhost, https://doi.org/10.1016/j.bbmt.2011.05.016.

APA

Indira Sahdev, David A. Jacobsohn, Eric Sandler, Donna A. Wall, Jean E. Sanders, Michael Kellick, Kirk R. Schultz, Stephan A. Grupp, Andrew L. Gilman, Ka Wah Chan, Kamar Godder, Robin Ryan, George E. Sale, Steven Neudorf, Frederick D. Goldman, Bryan Langholz, Mark Krailo, & Zhengjia Chen. (2012). Randomized Trial of Hydroxychloroquine for Newly Diagnosed Chronic Graft-versus-Host Disease in Children: A Children’s Oncology Group Study. Biology of Blood and Marrow Transplantation, 18, 84–91. https://doi.org/10.1016/j.bbmt.2011.05.016

Chicago

Indira Sahdev, David A. Jacobsohn, Eric Sandler, Donna A. Wall, Jean E. Sanders, Michael Kellick, Kirk R. Schultz, et al. 2012. “Randomized Trial of Hydroxychloroquine for Newly Diagnosed Chronic Graft-versus-Host Disease in Children: A Children’s Oncology Group Study.” Biology of Blood and Marrow Transplantation 18 (January): 84–91. doi:10.1016/j.bbmt.2011.05.016.